Laboratorios Farmaceuticos Rovi, S.A. (VIE:ROVI)
Austria flag Austria · Delayed Price · Currency is EUR
80.25
-0.65 (-0.80%)
Last updated: Mar 6, 2026, 1:00 PM CET

VIE:ROVI Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
743.48763.75829.51817.7648.68
Revenue Growth (YoY)
-2.65%-7.93%1.44%26.06%54.46%
Cost of Revenue
271.9296.04346.17305.27268.84
Gross Profit
471.59467.71483.34512.43379.84
Selling, General & Admin
160.47158.26147.02129.99103.36
Other Operating Expenses
107.6102.7392.52105.8474.96
Operating Expenses
298.45289.01263.87258.69199.68
Operating Income
173.14178.71219.47253.74180.15
Interest Expense
-2.56-1.99-0.95-0.85-0.91
Interest & Investment Income
0.510.030.010.010.07
Earnings From Equity Investments
0.06-0.14-0.130.20.18
Currency Exchange Gain (Loss)
-0.210.3-0.09-0.82-0.18
Other Non Operating Income (Expenses)
12.330.792.093.933.4
EBT Excluding Unusual Items
183.26177.69220.41256.21182.72
Gain (Loss) on Sale of Investments
---1.76-
Asset Writedown
----0-0.1
Pretax Income
183.26177.69220.41257.97182.63
Income Tax Expense
42.940.8150.1158.329.55
Earnings From Continuing Operations
140.36136.88170.3199.67153.08
Minority Interest in Earnings
0.080.010.040-
Net Income
140.44136.88170.34199.67153.08
Net Income to Common
140.44136.88170.34199.67153.08
Net Income Growth
2.60%-19.64%-14.69%30.44%150.71%
Shares Outstanding (Basic)
5151535355
Shares Outstanding (Diluted)
5151535355
Shares Change (YoY)
-0.13%-3.73%-0.51%-3.50%0.03%
EPS (Basic)
2.752.673.203.732.76
EPS (Diluted)
2.752.673.203.732.76
EPS Growth
2.73%-16.53%-14.25%35.31%150.36%
Free Cash Flow
121.8779.1659.45186.88109.22
Free Cash Flow Per Share
2.381.551.123.501.97
Dividend Per Share
-0.9351.1041.2940.956
Dividend Growth
--15.28%-14.69%35.39%150.68%
Gross Margin
63.43%61.24%58.27%62.67%58.55%
Operating Margin
23.29%23.40%26.46%31.03%27.77%
Profit Margin
18.89%17.92%20.53%24.42%23.60%
Free Cash Flow Margin
16.39%10.37%7.17%22.86%16.84%
EBITDA
195.54199.62238.02271.33196.56
EBITDA Margin
26.30%26.14%28.69%33.18%30.30%
D&A For EBITDA
22.3920.9118.5417.5916.41
EBIT
173.14178.71219.47253.74180.15
EBIT Margin
23.29%23.40%26.46%31.03%27.77%
Effective Tax Rate
23.41%22.97%22.73%22.60%16.18%
Advertising Expenses
1821.7421.7519.9912.71
Source: S&P Global Market Intelligence. Standard template. Financial Sources.